Cartesian Therapeutics (RNAC) Interest Coverage Ratio (2015 - 2023)

Cartesian Therapeutics (RNAC) has 9 years of Interest Coverage Ratio data on file, last reported at 10.26 in Q3 2023.

• Interest Coverage Ratio for Q3 2023 came in at 10.26, down 414.76% year-over-year; the trailing twelve-month figure through Jun 2024 was 38.48 (down 158.84% YoY), and the FY2023 annual result was 30.5, down 735.96% from the prior year.
• Interest Coverage Ratio grew to 10.26 in Q3 2023 per RNAC's latest filing, from 24.78 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 19.38 in Q2 2022 and troughed at 79.84 in Q2 2020.
• A 5-year average of 19.9 and a median of 11.08 in 2020 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio jumped 2949.22% in 2022, then sank 414.76% in 2023.
• A 5-year view of Interest Coverage Ratio shows it stood at 37.52 in 2019, then jumped by 70.48% to 11.08 in 2020, then soared by 151.78% to 5.74 in 2021, then slumped by 283.55% to 10.53 in 2022, then increased by 2.51% to 10.26 in 2023.
• Business Quant data shows RNAC's Interest Coverage Ratio at 10.26 in Q3 2023, 24.78 in Q2 2023, and 22.75 in Q1 2023.